Factors associated with COVID-19 vaccine hesitancy in Senegal: A mixed study. Issue 5 (30th November 2022)

• Record Type: Journal Article
• Authors: Ba, Mouhamadou Faly; Faye, Adama; Kane, Babacar; Diallo, Amadou Ibra; Junot, Amandine; Gaye, Ibrahima; Bonnet, Emmanuel; Ridde, Valéry
• Is Part Of: Human vaccines & immunotherapeutics. Volume 18:Issue 5(2022)
• Publication Date: 2022-11-30
• Subjects: Vaccine hesitancy -- acceptability -- COVID-19 -- mixed method -- Senegal; Vaccines -- Periodicals; 615.372
• DOI: 10.1080/21645515.2022.2060020
• Languages: English
• ISSNs: 2164-5515

Abstract

ABSTRACT: This study was an explanatory, sequential, mixed-methods design conducted in Senegal. We collected quantitative data from December 24, 2020, to January 16, 2021, and qualitative data from February 19 to March 30, 2021. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years old. We performed descriptive, bivariate, and multivariate analyses with R software for the quantitative phase; and performed manual content analyses for the qualitative phase. We surveyed 607 people for the quantitative phase and interviewed 30 people for the qualitative phase. Individuals who hesitated or refused to be vaccinated represented 12.9% and 32.8%, respectively. Vaccine hesitancy was related to gender, living in large cities, having a poor attitude toward the vaccine, thinking that the vaccine would not help protect them from the virus, being influenced by people important to them, and lacking information from health professionals. Vaccine refusal was related to living in large cities, having a poor attitude toward the vaccine, thinking that the vaccine would not help protect them from the virus, thinking that the vaccine could endanger their health, trusting opinions of people who were important to them, and lacking information from health professionals. The results of the study show that the factors associated with COVID-19 vaccine hesitancy and refusal are diverse and complex. Addressing these factors will help to ensure better vaccination coverage. Governments and health authorities should intensify their efforts to promote vaccine confidence and reduce misinformation.